INO

Inovio Pharmaceuticals INC

-$3.0M

Net Activity

Institutions Holding

99

Popularity Rank

#4461

Avg Weight

0.01%

Total Value

$55.8M

Ownership Trend

99 institutions currently hold INO, with 35 net buyers and 37 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

37

Net Buying Institutions

35

Key Holders

View all 99 holding institutions

Quarterly Activity

Recent Activity

+$13.0M

Total Buy Value

$36.6M

Total Sell Value

New buy12
Trim22
Add23
Sold out15

35

Net Buyers

37

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding INOVIO PHARMACEUTICALS INC (INO)?
Major stakeholders currently include FMR LLC ($16.3M), Janus Henderson Group PLC ($5.8M), Vanguard Capital Management LLC ($5.0M). Based on the latest 13F filings, there are a total of 99 tracked investment funds and institutions maintaining positions in INO.
What is the overall institutional sentiment toward INO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.0M, driven by 35 managers accumulating shares while 37 reduced their exposure.
Which institutions have been selling or reducing their INO positions?
In the latest period, 22 funds trimmed their holdings, and 15 managers completely exited their positions. The aggregate reported sell value was $36.6M.
Are there any notable investors adding INO to their portfolios?
Yes, buying activity remains notable. 12 institutions opened new positions in {ticker}, and 23 existing holders added to their shares. The total reported buy value for the quarter amounted to $13.0M.

Related Stocks